Sector
HealthcareOpen
₹125.1Prev. Close
₹137.75Turnover(Lac.)
₹0.12Day's High
₹137Day's Low
₹125.152 Week's High
₹169.552 Week's Low
₹84.01Book Value
₹84.57Face Value
₹10Mkt Cap (₹ Cr.)
50.01P/E
54.37EPS
2.52Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 5.42 | 5.42 | 5.42 | 5.42 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 26.79 | 25.66 | 24.77 | 24.15 |
Net Worth | 32.21 | 31.08 | 30.19 | 29.57 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Revenue | 44.42 | 36.93 | 55.61 | 56.05 |
yoy growth (%) | 20.28 | -33.59 | -0.78 | 6.27 |
Raw materials | -19.65 | -10.36 | -24.28 | -25.03 |
As % of sales | 44.23 | 28.06 | 43.67 | 44.66 |
Employee costs | -10.77 | -9.97 | -10.67 | -9.46 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Profit before tax | 1.07 | 1.52 | 2.15 | 2.84 |
Depreciation | -1.52 | -1.55 | -1.55 | -0.69 |
Tax paid | -0.44 | -0.56 | -0.85 | -0.82 |
Working capital | -3.01 | 2.88 | 0.52 | 0.04 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2019 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 20.28 | -33.59 | -0.78 | 6.27 |
Op profit growth | -11.11 | -13.7 | 10.21 | 19.56 |
EBIT growth | -16.35 | -18.24 | -5.45 | 19.09 |
Net profit growth | -34.79 | -25.77 | -35.73 | 30.75 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,139.15 | 140.98 | 1,10,740.42 | 231.3 | 0.13 | 686.11 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,242 | 92.73 | 1,04,128.85 | 369.6 | 0.22 | 2,135.4 | 569.62 |
Fortis Healthcare Ltd FORTIS | 683.2 | 272.19 | 51,578.74 | 39.63 | 0.15 | 357.15 | 120.23 |
Syngene International Ltd SYNGENE | 847.15 | 77.65 | 34,100.92 | 96.6 | 0.15 | 821.3 | 107.27 |
Global Health Ltd MEDANTA | 1,095.85 | 77.39 | 29,433.15 | 104.47 | 0 | 664.61 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman / Executive Director / MD / CEO
Vijay Majrekar
Executive Director / Whole Time Director / CFO
Anuradha Kashikar
E D & Wholetime Director
Devraj T Poojary
Independent Non Exe. Director
B S Limaye
Independent Non Exe. Director
Sunil C Modi
Independent Non Exe. Director
Jagadish B Shetty
Independent Non Exe. Director
N M Vora
Independent Director
AKASH SUNIL MODI
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Centenial Surgical Suture Ltd
Summary
Incorporated in 1995, Centenial Surgical Suture is engaged in the manufacture and sale of surgical sutures in India. The company offers absorbable sutures that include natural and synthetic sutures and non absorbable sutures comprising needles for cardiovascular surgery, monofilament polyamide atraumatic needle suture combinations, monofilament stainless steel, and temporary pacemaker electrodes. It also provides female urinary incontinency sets, titanium haemostatic clips for cardiovascular surgery, non absorbable.
Read More
The Centenial Surgical Suture Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹137 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Centenial Surgical Suture Ltd is ₹50.01 Cr. as of 24 Dec ‘24
The PE and PB ratios of Centenial Surgical Suture Ltd is 54.37 and 1.62 as of 24 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Centenial Surgical Suture Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Centenial Surgical Suture Ltd is ₹84.01 and ₹169.5 as of 24 Dec ‘24
Centenial Surgical Suture Ltd's CAGR for 5 Years at 33.97%, 3 Years at 37.59%, 1 Year at 33.07%, 6 Month at 20.92%, 3 Month at 5.87% and 1 Month at 5.47%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice